A survey on hematology ‐oncology pediatric AIEOP centres: the challenge of posterior reversible encephalopathy syndrome

ConclusionsThis study demonstrates that PRES is a common neurological complication and occurring preferentially in course of induction treatment of some hematologic malignancies, as ALL and after HSCT. It also highlights great clinical differences in the management and outcome in patients with PRES occurring after chemotherapy or after HSCTThis article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - October 1, 2017 Category: Hematology Authors: Daniele Zama, Pietro Gasperini, Massimo Berger, Mariagrazia Petris, Maria D. De Pasquale, Simone Cesaro, Maria E. Guerzoni, Elena Mastrodicasa, Francesca Savina, Ottavio Ziino, Valentina Kiren, Paola Muggeo, Rosa M. Mura, Fraia Melchionda, Giulio A. Zanaz Tags: Original Article Source Type: research